tykhr
sign in
free sign up
Alvotech
Drug Manufacturers - Specialty & Generic
Healthcare
ALVO
313 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
8.35
52 week high
13.52
high
9.25
52 week low
0.00
low
8.21
growth
-21.76 %
previous Close
8.01
P/E ratio
market cap
2.65 B
div yield
0
usd
Jun 2025
qoq
revenue
0.00 %
net incoming
0.00 %
eps
0.00 %
0.00 %
eps surprise
100.00 %
net profit margin
0.00 %
-82.00 %
operating incoming
0.00 %
net change in cash
0.00 %
cash on hand
0.00 %
cost of revenue
0.00 %
top